From the press release at incelldx it looks like
Post# of 148163
(Total Views: 836)
Posted On: 07/18/2020 10:55:13 PM
From the press release at incelldx it looks like Incelldx patented RANTES as a diagnostic on COVID 19 and has a deal from last August which entitles them to use Leronlimab as a diagnostic for receptor occupancy.. To answer your question IMO , of course he is getting regular updates from Amerax and its almost certainly great news!
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼